801,177 Shares in HCA Healthcare, Inc. $HCA Purchased by Life Cycle Investment Partners Ltd

Life Cycle Investment Partners Ltd bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, HoldingsChannel reports. The institutional investor bought 801,177 shares of the company’s stock, valued at approximately $374,037,000. HCA Healthcare comprises 2.6% of Life Cycle Investment Partners Ltd’s portfolio, making the stock its 11th biggest position.

A number of other hedge funds have also recently bought and sold shares of HCA. Viking Global Investors LP grew its holdings in HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares during the period. Northwestern Mutual Wealth Management Co. grew its holdings in HCA Healthcare by 4,545.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after acquiring an additional 649,058 shares during the period. Danske Bank A S acquired a new position in HCA Healthcare during the third quarter worth about $115,530,000. Zurich Insurance Group Ltd FI increased its stake in HCA Healthcare by 3,755.9% in the 3rd quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock worth $115,036,000 after purchasing an additional 262,912 shares in the last quarter. Finally, Mondrian Investment Partners LTD purchased a new position in HCA Healthcare in the 3rd quarter worth about $106,605,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently weighed in on HCA. The Goldman Sachs Group lifted their price target on HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Stephens reduced their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a report on Monday, April 27th. TD Cowen reduced their target price on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a report on Monday, April 27th. Leerink Partners lowered their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Finally, JPMorgan Chase & Co. lowered their target price on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 19th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $515.77.

HCA Healthcare Price Performance

NYSE:HCA opened at $394.40 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The stock’s 50-day moving average is $465.16 and its two-hundred day moving average is $483.61. The stock has a market cap of $87.49 billion, a PE ratio of 13.56, a price-to-earnings-growth ratio of 1.25 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s payout ratio is currently 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.